KMDA Kamada Ltd.

Kamada Ltd is an orphan drug, plasma-derived protein therapeutics company and develops & produces specialty plasma-derived protein therapeutics. Its flagship product include Glassia.

Note: This is not a U.S. company, but they cross-list their shares on a U.S. stock exchange - see the related symbol IT:KMDA.

As of 10/05/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Israel
Country of incorporation:  Israel
IPO date:  05/31/2013
Outstanding shares:  44,819,958
Average volume:  48,364
Market cap:   $200,793,412
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      B2Q9833
Valuation   (See tab for details)
PE ratio:   -92.66
PB ratio:   1.20
PS ratio:   1.94
Return on equity:   -1.26%
Net income %:   -2.15%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy